Irish Blood Transfusion Service

SCIB Celebrates Sarawak Day With Life-Saving Blood Donation Drive

Retrieved on: 
Friday, July 21, 2023
Social responsibility, Irish Blood Transfusion Service, Sarawak General Hospital, SCIB, Philosophy, Blood, ESG, Medical device

KUCHING, MALAYSIA, July 21, 2023 - (ACN Newswire) - Civil engineering specialist Sarawak Consolidated Industries Berhad ("SCIB" or the "Company") is pleased to announce that they have organised their annual blood donation drive in collaboration with the Sarawak General Hospital Blood Bank in honor of Sarawak Day.

Key Points: 
  • KUCHING, MALAYSIA, July 21, 2023 - (ACN Newswire) - Civil engineering specialist Sarawak Consolidated Industries Berhad ("SCIB" or the "Company") is pleased to announce that they have organised their annual blood donation drive in collaboration with the Sarawak General Hospital Blood Bank in honor of Sarawak Day.
  • The initiative, known as "SCIB Blood Donation Day", is part of the company's ongoing commitment to giving back to society.
  • "This blood donation drive not only aligns with our social responsibility but also embodies the spirit of Sarawak Day - unity and care for one another.
  • The SCIB Blood Donation Day is one of many initiatives demonstrating how SCIB fulfils its ESG commitments while making a real difference to people's lives.

Trusting Heart Blood Center Holds Ribbon Cutting Ceremony for Opening of its Second Platelet Donation Site

Retrieved on: 
Tuesday, March 15, 2022
Quality of life, GLOBE, Patient, Hospital, Collection, Risk, Triangle, Hope, Degenerative disease, Cancer, Blood, Bleeding, Industry, Irish Blood Transfusion Service, Duke University Hospital, World Blood Donor Day, Blood product, Medical device, THBC

RALEIGH, N.C. and DURHAM, N.C., March 15, 2022 (GLOBE NEWSWIRE) -- Trusting Heart Blood Center (THBC) will hold a ribbon cutting ceremony today from 4:30 to 6:30 PM EDT to commemorate the opening of its new platelet collection facility at 10441 Moncreiffe Rd, Raleigh, North Carolina.

Key Points: 
  • RALEIGH, N.C. and DURHAM, N.C., March 15, 2022 (GLOBE NEWSWIRE) -- Trusting Heart Blood Center (THBC) will hold a ribbon cutting ceremony today from 4:30 to 6:30 PM EDT to commemorate the opening of its new platelet collection facility at 10441 Moncreiffe Rd, Raleigh, North Carolina.
  • The U.S. continues to face rising blood and platelet shortages that are causing hospitals to postpone vital treatments and surgeries, threatening the well-being of patients and healthcare institutions alike, said Derek Dagendesh of Trusting Heart Blood Center.
  • We hope with the opening of this second platelet collection center, we will continue to partner with hospitals amidst the growing platelet shortage.
  • Trusting Heart Blood Center is committed to working with hospitals to help ensure a readily available supply.

Cerus Corporation Applauds FDA Requirements Effective Today to Safeguard the U.S. Platelet Supply

Retrieved on: 
Friday, October 1, 2021
General Health, FDA, Medical Devices, Health, Pharmaceutical, Irish Blood Transfusion Service, Food, Safety, Bleeding, Transfusion-associated graft-versus-host disease, Compliance, Standard of care, Transfusion, Factor, Health, FDA, Patient, Centers for Disease Control and Prevention, Parasitism, LinkedIn, Hospital, Virus, Bacteria, Vertically transmitted infection, CERS, Risk, Availability, Center, Transfusion medicine, CE, United, Cryoprecipitate, Industry, Plasma, Vaccine, Blood product, Medical device

Today marks the effective date for the U.S. Food and Drug Administrations (FDA) final guidance document on bacterial risk control strategies for platelet collection and transfusion.

Key Points: 
  • Today marks the effective date for the U.S. Food and Drug Administrations (FDA) final guidance document on bacterial risk control strategies for platelet collection and transfusion.
  • For two decades, the INTERCEPT Blood System for platelets and plasma has been used around the world to help safeguard the supply of platelets and plasma.
  • Today, Cerus INTERCEPT Blood System for platelets is the only FDA-approved pathogen reduction measure currently available in the U.S. for compliance with the FDA guidance.
  • INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021

Retrieved on: 
Monday, September 20, 2021
Medical Devices, FDA, Health, Hospitals, General Health, Pharmaceutical, Food, Assistant, Centers for Medicare & Medicaid Services, Bleeding, Factor, Regulation of tobacco by the U.S. Food and Drug Administration, Fibrinogen, Health, Irish Blood Transfusion Service, FDA, HCPCS, Medicare, Patient, CMS, Therapy, Master of Science, LinkedIn, Hospital, Corporation, CERS, NTAP, HCPCS Level 2, Society, Plasma, CE, Kaiser Permanente, Safety, Doctor of Philosophy, Nasdaq, Cryoprecipitate, Industry, Department, Online shopping, Pharmaceutical industry

Cerus Corporation (Nasdaq: CERS) today announced its participation in the Society for the Advancement of Blood Management (SABM) Virtual Annual Meeting, which is scheduled for September 22-25, 2021.

Key Points: 
  • Cerus Corporation (Nasdaq: CERS) today announced its participation in the Society for the Advancement of Blood Management (SABM) Virtual Annual Meeting, which is scheduled for September 22-25, 2021.
  • On Thursday, September 23, Cerus will host an industry workshop, Clinical need for and experience with the new Pathogen Reduced Cryoprecipitated Fibrinogen Complex (INTERCEPT Fibrinogen Complex), from 1:00-1:30p.m.
  • Cerus received approval from the U.S. Food and Drug Administration (FDA) in November 2020 for the INTERCEPT Blood System for Cryoprecipitation, which is used to produce INTERCEPT Fibrinogen Complex as well as Pathogen Reduced Plasma, Cryoprecipitate Reduced.
  • INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.

Fenway Health Commends FDA for New Blood Donation Guidance Amid COVID-19 Health Emergency

Retrieved on: 
Friday, April 3, 2020
Articles, Health, Contents, Transfusion medicine, Hematology, Blood donation, Public health, World Health Organization, Irish Blood Transfusion Service

The new guidance was one of four recommendations for blood donation announced today to increase the nation's blood supply, which has reached dangerously low levels during the COVID-19 pandemic.

Key Points: 
  • The new guidance was one of four recommendations for blood donation announced today to increase the nation's blood supply, which has reached dangerously low levels during the COVID-19 pandemic.
  • "As we adapt to meet the critical needs of our health care system during this public health emergency, we must be guided by science and research.
  • Additionally, the new guidance reduces the recommended blood donation deferral period from 12 months to three months for people who have received tattoos or piercings.
  • The Fenway Institute at Fenway Health is an interdisciplinary center for research, training, education and policy development focusing on national and international health issues.